These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 6359877

  • 1. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.
    Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U.
    Am J Med; 1983 Dec; 75(6):920-7. PubMed ID: 6359877
    [Abstract] [Full Text] [Related]

  • 2. Results of a controlled drug trial in membranoproliferative glomerulonephritis.
    Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN.
    Kidney Int; 1985 Feb; 27(2):436-41. PubMed ID: 3886998
    [Abstract] [Full Text] [Related]

  • 3. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT, Edmondson RP, Yap HK, Wu AY, Chiang GS, Lee EJ, Pwee HS, Lim CH.
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [Abstract] [Full Text] [Related]

  • 4. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG, Yu SH, Owen JE, Kincaid-Smith P.
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
    [Abstract] [Full Text] [Related]

  • 6. Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.
    Chapman SJ, Cameron JS, Chantler C, Turner D.
    Arch Dis Child; 1980 Jun; 55(6):446-51. PubMed ID: 7436483
    [Abstract] [Full Text] [Related]

  • 7. Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS).
    Zäuner I, Böhler J, Braun N, Grupp C, Heering P, Schollmeyer P.
    Nephrol Dial Transplant; 1994 Jun; 9(6):619-22. PubMed ID: 7970086
    [Abstract] [Full Text] [Related]

  • 8. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
    Woo KT, Lee GS, Lau YK, Chiang GS, Lim CH.
    Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
    [Abstract] [Full Text] [Related]

  • 9. Dipyridamole (persantin) and warfarin in the treatment of glomerulonephritis.
    First MR, Goldberg B, Abrahams C.
    S Afr Med J; 1972 Jun 17; 46(25):848-9. PubMed ID: 5076072
    [No Abstract] [Full Text] [Related]

  • 10. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
    Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesebro JH.
    N Engl J Med; 1984 May 31; 310(22):1421-6. PubMed ID: 6371535
    [Abstract] [Full Text] [Related]

  • 11. Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.
    Harmankaya O, Baştürk T, Oztürk Y, Karabiber N, Obek A.
    Int Urol Nephrol; 2001 May 31; 33(3):583-7. PubMed ID: 12230299
    [Abstract] [Full Text] [Related]

  • 12. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
    Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV.
    Am J Cardiol; 1983 May 15; 51(9):1537-41. PubMed ID: 6342354
    [Abstract] [Full Text] [Related]

  • 13. Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis.
    Donadio JV, Offord KP.
    Am J Kidney Dis; 1989 Dec 15; 14(6):445-51. PubMed ID: 2596471
    [Abstract] [Full Text] [Related]

  • 14. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
    Lee GS, Woo KT, Lim CH.
    Clin Nephrol; 1989 May 15; 31(5):276. PubMed ID: 2661066
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of dipyridamole with anticoagulants in the treatment of glomerulonephritis.
    Kalowski S, Kincaid-Smith P.
    Med J Aust; 1973 Jul 28; 2(4):164-6. PubMed ID: 4741342
    [No Abstract] [Full Text] [Related]

  • 16. Low-dosage heparin in rapidly progressive glomerulonephritis.
    Fye KH, Hancock D, Moutsopoulos H, Humes HD, Arieff AI.
    Arch Intern Med; 1976 Sep 28; 136(9):995-9. PubMed ID: 962457
    [Abstract] [Full Text] [Related]

  • 17. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.
    Brown CB, Wilson D, Turner D, Cameron JS, Ogg CS, Chantler C, Gill D.
    Lancet; 1974 Nov 16; 2(7890):1166-72. PubMed ID: 4139590
    [No Abstract] [Full Text] [Related]

  • 18. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
    Mathew TH, Kincaid-Smith P.
    Perspect Nephrol Hypertens; 1973 Nov 16; 1 Pt 2(0):727-34. PubMed ID: 4803314
    [No Abstract] [Full Text] [Related]

  • 19. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
    Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, Chow J, Ng RP, Tse TF.
    Circulation; 1985 Nov 16; 72(5):1059-63. PubMed ID: 3899404
    [Abstract] [Full Text] [Related]

  • 20. Rapidly progressive glomerulonephritis treated with anticoagulants.
    Arieff AI, Pinggera WF.
    Arch Intern Med; 1972 Jan 16; 129(1):77-84. PubMed ID: 4550298
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.